Natera (NTRA) Tops Q4 Earnings and Revenue Estimates

Core Viewpoint - Natera reported quarterly earnings of $0.35 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.46 per share, marking an earnings surprise of +175.43% [1] Financial Performance - The company achieved revenues of $665.5 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.76% and showing a year-over-year increase from $476.06 million [2] - Over the last four quarters, Natera has exceeded consensus EPS estimates two times and topped revenue estimates four times [2] Stock Performance and Outlook - Natera shares have declined approximately 7.5% since the beginning of the year, contrasting with the S&P 500's gain of 1.5% [3] - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at -$0.57 for the upcoming quarter and -$1.74 for the current fiscal year [7] Industry Context - The Medical Services industry, to which Natera belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and earnings estimate revisions, which could impact Natera's stock trajectory [5]